Status:
public
Videos: (
0
) Documents: (
0
) Comments: (
0
)
Group description
Group Videos
No videos have been added jet. You may join this group and add yours now.
Group Documents
No documents have been added jet. You may join this group and add yours now.
News
- Seattle Genetics to Present at Upcoming Investor Conference
Seattle Genetics, Inc. announced today that management will present at the following upcoming investor conference. The presentation will be webcast live and available - Interleukin Genetics, Inc. to Present at 14th Annual BIO CEO & Investor Conference
Interleukin Genetics, Inc. announced today that CEO Lewis H. Bender will present at the 14th Annual BIO CEO & Investor Conference on Tuesday, February 14 at the Waldorf Astoria, in New York City. - Response Genetics Raises More Than $7.8 Million in Financing
Response Genetics, Inc. announced today that it has entered into purchase agreements with investors to raise more than $7.8 million from the private placement of appr - Signal Genetics Announces Acquisition of ChipDX LLC and Expansion of Molecular Diagnostics Assets in Oncology
Signal Genetics, a privately held predictive genetic testing company focused on oncology, today announced an agreement with New York based ChipDX LLC , under which Signal will acquire all of the assets of ChipDX, including patents for prognostic tests in lung, breast, and colon cancers. - Seattle Genetics to Host Conference Call and Webcast Discussion of Fourth Quarter and Year 2011 Financial Results on ...
Seattle Genetics, Inc. announced today that it will report its fourth quarter and year 2011 financial results on Monday, February 13, 2012, after the close of financial markets. - Seattle Genetics Inc. Fourth Quarter Earnings Sneak Peek
Here's what you need to know for the upcoming earnings release ... - Response Genetics to Present at the 22nd Annual UBS Global Healthcare Services Conference
Response Genetics, Inc. , a company focused on the development and sale of molecular diagnostic tests for cancer, announced today that Thomas Bologna, CEO and Chairma - Viral Genetics Inc. Issues 2011 Year in Review and 2012 Outlook
Viral Genetics, Inc. today posted to its website a President’s Letter to Shareholders that reviews the past year and looks ahead to what 2012 holds for the Company. - Myriad Genetics Reports Second Quarter Fiscal Year 2012 Results
SALT LAKE CITY -- Myriad Genetics, Inc. today announced results for its second fiscal quarter and six months ending December 31, 2011. Revenue for the second fiscal quarter was $122.8 million, an increase ... - Myriad Genetics to Present at the Leerink Swann 2012 Global Healthcare Conference
SALT LAKE CITY -- Myriad Genetics, Inc. announced today that Jim Evans, Chief Financial Officer, is scheduled to present at the Leerink Swann 2012 Global Healthcare Conference, at 11:00 a.m. Eastern Time ...